Sean Cowan   •   about 10 years ago

Design Elements Content

I don't see MOA content in the sample trial data link provided. Can we use MOA content from a different study and still meet the requirements?

Also, can you point to where the Patient Considerations content (Risk/Benefits, Study Logistics and Post Plan Study) content can be pulled from. It is not as obvious as the other required fields.

• 4 comments
• 

  Zeeshan Sheikh   •   about 10 years ago

  The Patient Considerations content needs to be extracted from the other resources.

  The MOA is actually there as well (for this study), you have to extract it from the content as well. (or well, at least I hope that what I have is MOA :) )

• 

  Zeeshan Sheikh   •   about 10 years ago

  For Pemetrexed I used: Binds to folate receptor

• 

  Megan Arend Manager   •   about 10 years ago

  Hi Sean,

  Information on Risks/Benefit of study participation, Study Logistics and Post Study Plans can be found in the Informed Consent document: http://challenges.s3.amazonaws.com/eli-lilly/Sample%20Study%20Informed%20Consent%20Document.pdf.

  If you're having trouble identifying the correct content, please read through this Definitions Document, which explains the meaning of each section and field, and tells you the type of content that belongs in each: http://challenges.s3.amazonaws.com/eli-lilly/Clinical%20Trial%20Visualization%20Redesign%20Definitions.pdf.

  As for the Mechanism of Action information, please visit the ClinicalTrials.gov page for this study: http://www.clinicaltrials.gov/ct2/show/NCT00789373. On the Full Text View, you'll see that there is a section that says "Resource links provided by NLM." Under that section, you'll see that there are links for "Drug Information." There you'll find the appropriate information for Mechanism of Action.

  Thanks,
  Megan

• 

  Megan Arend Manager   •   about 10 years ago

  Thanks, zxed, for your help as well!

Comments are closed.